HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 173 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $451,000 | -25.9% | 10,839 | -53.2% | 0.01% | -33.3% |
Q3 2020 | $609,000 | +33.6% | 23,159 | -10.0% | 0.02% | +114.3% |
Q4 2019 | $456,000 | +204.0% | 25,742 | +150.5% | 0.01% | +40.0% |
Q4 2018 | $150,000 | -83.1% | 10,277 | -77.2% | 0.01% | -64.3% |
Q1 2018 | $885,000 | +61.2% | 45,130 | +5.3% | 0.01% | +133.3% |
Q2 2017 | $549,000 | +104.9% | 42,849 | +107.1% | 0.01% | +100.0% |
Q1 2017 | $268,000 | +45.7% | 20,687 | +51.0% | 0.00% | -25.0% |
Q3 2015 | $184,000 | +34.3% | 13,700 | -3.7% | 0.00% | -33.3% |
Q4 2014 | $137,000 | – | 14,226 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |